The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Non-opioid Pain Patch-Global Market Insights and Sales Trends 2024
Synopsis
A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The global Non-opioid Pain Patch market size is expected to reach US$ 779.5 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Non-opioid Pain Patch in various end use industries. The expanding demands from the OTC and Rx, are propelling Non-opioid Pain Patch market. Lidocaine Patches, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diclofenac Patches segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Non-opioid Pain Patch market, driven by demand from China, the second largest economy with some signs of stabilising, the Non-opioid Pain Patch market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Non-opioid Pain Patch, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Non-opioid Pain Patch market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Non-opioid Pain Patch market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Non-opioid Pain Patch sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Non-opioid Pain Patch covered in this report include Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis and Qizheng, etc.
The global Non-opioid Pain Patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hisamitsu
Mylan
Johnson & Johnson
Actavis
Lingrui
Teikoku Seiyaku
Sanofi
Novartis
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
BLUE-EMU
Global Non-opioid Pain Patch market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Non-opioid Pain Patch market, Segment by Type:
Lidocaine Patches
Diclofenac Patches
Indomethacin Patches
Counter-Irritant Patches
Fentanyl Patches
Others
Global Non-opioid Pain Patch market, by Application
OTC
Rx
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Non-opioid Pain Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Non-opioid Pain Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The global Non-opioid Pain Patch market size is expected to reach US$ 779.5 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Non-opioid Pain Patch in various end use industries. The expanding demands from the OTC and Rx, are propelling Non-opioid Pain Patch market. Lidocaine Patches, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diclofenac Patches segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Non-opioid Pain Patch market, driven by demand from China, the second largest economy with some signs of stabilising, the Non-opioid Pain Patch market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Non-opioid Pain Patch, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Non-opioid Pain Patch market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Non-opioid Pain Patch market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Non-opioid Pain Patch sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Non-opioid Pain Patch covered in this report include Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis and Qizheng, etc.
The global Non-opioid Pain Patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hisamitsu
Mylan
Johnson & Johnson
Actavis
Lingrui
Teikoku Seiyaku
Sanofi
Novartis
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
BLUE-EMU
Global Non-opioid Pain Patch market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Non-opioid Pain Patch market, Segment by Type:
Lidocaine Patches
Diclofenac Patches
Indomethacin Patches
Counter-Irritant Patches
Fentanyl Patches
Others
Global Non-opioid Pain Patch market, by Application
OTC
Rx
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Non-opioid Pain Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Non-opioid Pain Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Non-opioid Pain Patch Market Overview
1.1 Non-opioid Pain Patch Product Overview
1.2 Non-opioid Pain Patch Market Segment by Type
1.2.1 Lidocaine Patches
1.2.2 Diclofenac Patches
1.2.3 Indomethacin Patches
1.2.4 Counter-Irritant Patches
1.2.5 Fentanyl Patches
1.2.6 Others
1.3 Global Non-opioid Pain Patch Market Size by Type
1.3.1 Global Non-opioid Pain Patch Market Size Overview by Type (2018-2029)
1.3.2 Global Non-opioid Pain Patch Historic Market Size Review by Type (2018-2023)
1.3.3 Global Non-opioid Pain Patch Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Non-opioid Pain Patch Sales Breakdown by Type (2018-2023)
1.4.2 Europe Non-opioid Pain Patch Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Non-opioid Pain Patch Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Non-opioid Pain Patch Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Non-opioid Pain Patch Sales Breakdown by Type (2018-2023)
2 Global Non-opioid Pain Patch Market Competition by Company
2.1 Global Top Players by Non-opioid Pain Patch Sales (2018-2023)
2.2 Global Top Players by Non-opioid Pain Patch Revenue (2018-2023)
2.3 Global Top Players by Non-opioid Pain Patch Price (2018-2023)
2.4 Global Top Manufacturers Non-opioid Pain Patch Manufacturing Base Distribution, Sales Area, Product Type
2.5 Non-opioid Pain Patch Market Competitive Situation and Trends
2.5.1 Non-opioid Pain Patch Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Non-opioid Pain Patch Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-opioid Pain Patch as of 2022)
2.7 Date of Key Manufacturers Enter into Non-opioid Pain Patch Market
2.8 Key Manufacturers Non-opioid Pain Patch Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Non-opioid Pain Patch Status and Outlook by Region
3.1 Global Non-opioid Pain Patch Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Non-opioid Pain Patch Historic Market Size by Region
3.2.1 Global Non-opioid Pain Patch Sales in Volume by Region (2018-2023)
3.2.2 Global Non-opioid Pain Patch Sales in Value by Region (2018-2023)
3.2.3 Global Non-opioid Pain Patch Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Non-opioid Pain Patch Forecasted Market Size by Region
3.3.1 Global Non-opioid Pain Patch Sales in Volume by Region (2024-2029)
3.3.2 Global Non-opioid Pain Patch Sales in Value by Region (2024-2029)
3.3.3 Global Non-opioid Pain Patch Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Non-opioid Pain Patch by Application
4.1 Non-opioid Pain Patch Market Segment by Application
4.1.1 OTC
4.1.2 Rx
4.2 Global Non-opioid Pain Patch Market Size by Application
4.2.1 Global Non-opioid Pain Patch Market Size Overview by Application (2018-2029)
4.2.2 Global Non-opioid Pain Patch Historic Market Size Review by Application (2018-2023)
4.2.3 Global Non-opioid Pain Patch Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Non-opioid Pain Patch Sales Breakdown by Application (2018-2023)
4.3.2 Europe Non-opioid Pain Patch Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Non-opioid Pain Patch Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Non-opioid Pain Patch Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Non-opioid Pain Patch Sales Breakdown by Application (2018-2023)
5 North America Non-opioid Pain Patch by Country
5.1 North America Non-opioid Pain Patch Historic Market Size by Country
5.1.1 North America Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Non-opioid Pain Patch Sales in Volume by Country (2018-2023)
5.1.3 North America Non-opioid Pain Patch Sales in Value by Country (2018-2023)
5.2 North America Non-opioid Pain Patch Forecasted Market Size by Country
5.2.1 North America Non-opioid Pain Patch Sales in Volume by Country (2024-2029)
5.2.2 North America Non-opioid Pain Patch Sales in Value by Country (2024-2029)
6 Europe Non-opioid Pain Patch by Country
6.1 Europe Non-opioid Pain Patch Historic Market Size by Country
6.1.1 Europe Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Non-opioid Pain Patch Sales in Volume by Country (2018-2023)
6.1.3 Europe Non-opioid Pain Patch Sales in Value by Country (2018-2023)
6.2 Europe Non-opioid Pain Patch Forecasted Market Size by Country
6.2.1 Europe Non-opioid Pain Patch Sales in Volume by Country (2024-2029)
6.2.2 Europe Non-opioid Pain Patch Sales in Value by Country (2024-2029)
7 Asia-Pacific Non-opioid Pain Patch by Region
7.1 Asia-Pacific Non-opioid Pain Patch Historic Market Size by Region
7.1.1 Asia-Pacific Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Non-opioid Pain Patch Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Non-opioid Pain Patch Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Non-opioid Pain Patch Forecasted Market Size by Region
7.2.1 Asia-Pacific Non-opioid Pain Patch Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Non-opioid Pain Patch Sales in Value by Region (2024-2029)
8 Latin America Non-opioid Pain Patch by Country
8.1 Latin America Non-opioid Pain Patch Historic Market Size by Country
8.1.1 Latin America Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Non-opioid Pain Patch Sales in Volume by Country (2018-2023)
8.1.3 Latin America Non-opioid Pain Patch Sales in Value by Country (2018-2023)
8.2 Latin America Non-opioid Pain Patch Forecasted Market Size by Country
8.2.1 Latin America Non-opioid Pain Patch Sales in Volume by Country (2024-2029)
8.2.2 Latin America Non-opioid Pain Patch Sales in Value by Country (2024-2029)
9 Middle East and Africa Non-opioid Pain Patch by Country
9.1 Middle East and Africa Non-opioid Pain Patch Historic Market Size by Country
9.1.1 Middle East and Africa Non-opioid Pain Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Non-opioid Pain Patch Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Non-opioid Pain Patch Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Non-opioid Pain Patch Forecasted Market Size by Country
9.2.1 Middle East and Africa Non-opioid Pain Patch Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Non-opioid Pain Patch Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Hisamitsu
10.1.1 Hisamitsu Company Information
10.1.2 Hisamitsu Introduction and Business Overview
10.1.3 Hisamitsu Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Hisamitsu Non-opioid Pain Patch Products Offered
10.1.5 Hisamitsu Recent Development
10.2 Mylan
10.2.1 Mylan Company Information
10.2.2 Mylan Introduction and Business Overview
10.2.3 Mylan Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Mylan Non-opioid Pain Patch Products Offered
10.2.5 Mylan Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Company Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Johnson & Johnson Non-opioid Pain Patch Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 Actavis
10.4.1 Actavis Company Information
10.4.2 Actavis Introduction and Business Overview
10.4.3 Actavis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Actavis Non-opioid Pain Patch Products Offered
10.4.5 Actavis Recent Development
10.5 Lingrui
10.5.1 Lingrui Company Information
10.5.2 Lingrui Introduction and Business Overview
10.5.3 Lingrui Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Lingrui Non-opioid Pain Patch Products Offered
10.5.5 Lingrui Recent Development
10.6 Teikoku Seiyaku
10.6.1 Teikoku Seiyaku Company Information
10.6.2 Teikoku Seiyaku Introduction and Business Overview
10.6.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Teikoku Seiyaku Non-opioid Pain Patch Products Offered
10.6.5 Teikoku Seiyaku Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sanofi Non-opioid Pain Patch Products Offered
10.7.5 Sanofi Recent Development
10.8 Novartis
10.8.1 Novartis Company Information
10.8.2 Novartis Introduction and Business Overview
10.8.3 Novartis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Novartis Non-opioid Pain Patch Products Offered
10.8.5 Novartis Recent Development
10.9 Qizheng
10.9.1 Qizheng Company Information
10.9.2 Qizheng Introduction and Business Overview
10.9.3 Qizheng Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Qizheng Non-opioid Pain Patch Products Offered
10.9.5 Qizheng Recent Development
10.10 Endo
10.10.1 Endo Company Information
10.10.2 Endo Introduction and Business Overview
10.10.3 Endo Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Endo Non-opioid Pain Patch Products Offered
10.10.5 Endo Recent Development
10.11 Huarun 999
10.11.1 Huarun 999 Company Information
10.11.2 Huarun 999 Introduction and Business Overview
10.11.3 Huarun 999 Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Huarun 999 Non-opioid Pain Patch Products Offered
10.11.5 Huarun 999 Recent Development
10.12 GSK
10.12.1 GSK Company Information
10.12.2 GSK Introduction and Business Overview
10.12.3 GSK Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.12.4 GSK Non-opioid Pain Patch Products Offered
10.12.5 GSK Recent Development
10.13 Haw Par
10.13.1 Haw Par Company Information
10.13.2 Haw Par Introduction and Business Overview
10.13.3 Haw Par Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Haw Par Non-opioid Pain Patch Products Offered
10.13.5 Haw Par Recent Development
10.14 Nichiban
10.14.1 Nichiban Company Information
10.14.2 Nichiban Introduction and Business Overview
10.14.3 Nichiban Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Nichiban Non-opioid Pain Patch Products Offered
10.14.5 Nichiban Recent Development
10.15 Mentholatum
10.15.1 Mentholatum Company Information
10.15.2 Mentholatum Introduction and Business Overview
10.15.3 Mentholatum Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Mentholatum Non-opioid Pain Patch Products Offered
10.15.5 Mentholatum Recent Development
10.16 Laboratoires Genevrier
10.16.1 Laboratoires Genevrier Company Information
10.16.2 Laboratoires Genevrier Introduction and Business Overview
10.16.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Laboratoires Genevrier Non-opioid Pain Patch Products Offered
10.16.5 Laboratoires Genevrier Recent Development
10.17 BLUE-EMU
10.17.1 BLUE-EMU Company Information
10.17.2 BLUE-EMU Introduction and Business Overview
10.17.3 BLUE-EMU Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
10.17.4 BLUE-EMU Non-opioid Pain Patch Products Offered
10.17.5 BLUE-EMU Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Non-opioid Pain Patch Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Non-opioid Pain Patch Industrial Chain Analysis
11.4 Non-opioid Pain Patch Market Dynamics
11.4.1 Non-opioid Pain Patch Industry Trends
11.4.2 Non-opioid Pain Patch Market Drivers
11.4.3 Non-opioid Pain Patch Market Challenges
11.4.4 Non-opioid Pain Patch Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Non-opioid Pain Patch Distributors
12.3 Non-opioid Pain Patch Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
